Atlas Venture - We build breakthrough biotechnology companies.

Creating and building breakthrough biotechs for over 30 years

Partnering with the world's best life science entrepreneurs

Translating groundbreaking science into life-changing medicines

Scroll to explore

Scorpion, fresh off Lilly deal, spins out startup Antares

Movement disorder biotech Vima steps onto scene with $60M

Vertex challenger Sionna prices $191M IPO

Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal

Thirty years at the leading-edge of medical innovation and we’re just getting started.